Literatur
- 1
Altwein J E, Keuler F U.
Oral treatment of erectile dysfunction with apomorphine SL.
Urol Int.
2001;
67
257-263
- 2
Anderson K M, Odell P M, Wilson P W, Kannel W B.
Cardiovascular disease risk profiles.
Am Heart J.
1991;
121
293-298
- 3
Brock G B, McMahon C G, Chen K K, Costigan T, Shen W, Watkins V, Anglin G, Whitaker S.
Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results
of integrated analyses.
J Urol.
2002;
168
1332-1336
- 4
Chung W S, Shim B S, Park Y Y.
Hemodynamic insult by vascular risk factors and pharmacologic erection in men with
erectile dysfunction: Doppler sonography study.
World J Urol.
2000;
18
427-430
- 5
Conti C R, Pepine C J, Sweeney M.
Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction
in patients with ischemic heart disease.
Am J Cardiol.
1999;
83
29C-34C
- 6
DeBusk R, Drory Y, Goldstein I, Jackson G, Kaul S, Kimmel S E, Kostis J B, Kloner R A,
Lakin M, Meston C M, Mittleman M, Muller J E, Padma-Nathan H, Rosen R C, Stein R A,
Zusman R.
Management of sexual dysfunction in patients with cardiovascular disease: recommendations
of the Princeton Consensus Panel.
Am J Cardiol.
2000;
86
62F-68F
- 7
DeBusk R F.
Evaluating the cardiovascular tolerance for sex.
Am J Cardiol.
2000;
86
51F-56F
- 8
Dhabuwala C B, Kumar A, Pierce J M.
Myocardial infarction and its influence on male sexual function.
Arch Sex Behav.
1986;
15
499-504
- 9
Drory Y, Fisman E Z, Shapira Y, Pines A.
Ventricular arrhythmias during sexual activity in patients with coronary artery disease.
Chest.
1996;
109
922-924
- 10
Eardley I, Cartledge J.
Tadalafil (Cialis) for men with erectile dysfunction.
Int J Clin Pract.
2002;
56
300-304
- 11
Emmick J T, Stuewe S R, Mitchell M.
Overview of the cardiovascular effects of tadalafil (Ref Type: Generic).
Eur Heart J.
2002;
4
H32-H47
(Suppl H)
- 12
Ernst E, Pittler M H.
Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized
clinical trials.
J Urol.
1998;
159
433-436
- 13
Feldman H A, Goldstein I, Hatzichristou D G, Krane R J, McKinlay J B.
Impotence and its medical and psychosocial correlates: results of the Massachusetts
Male Aging Study.
J Urol.
1994;
151
54-61
- 14
Feldman H A, Johannes C B, Derby C A, Kleinman K P, Mohr B A, Araujo A B, McKinlay J B.
Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts
male aging study.
Prev Med.
2000;
30
328-338
- 15
Goldstein I, Lue T F, Padma-Nathan H, Rosen R C, Steers W D, Wicker P A.
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
N Engl J Med.
1998;
338
1397-1404
- 16
Hellerstein H K, Friedman E H.
Sexual activity and the postcoronary patient.
Arch Intern Med.
1970;
125
987-999
- 17
Hellstrom W J, Overstreet J W, Yu A, Saikali K, Shen W, Beasley C M, Watkins V S.
Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormones.
J Urol.
2003;
170
887-891
- 18
Horwitz L D.
Alcohol and heart disease.
JAMA.
1975;
232
959-960
- 19
Jackson G.
The use of sildenafil in heart disease.
Hosp Med.
2000;
61
526-527
- 20
Keene L C, Davies P H.
Drug-related erectile dysfunction.
Adverse Drug React Toxicol Rev.
1999;
18
5-24
- 21
Kimmel S E.
Sex and myocardial infarction: an epidemiologic perspective.
Am J Cardiol.
2000;
86
10F-13F
- 22
Ledda A.
Cigarette smoking, hypertension and erectile dysfunction.
Curr Med Res Opin.
2000;
16
s13-s16
(Suppl 1)
- 23
Maroto Montero J M, de Pablo Z C.
Cardiac rehabilitation in Spain. Preventive cardiology units.
Rev Esp Cardiol.
1998;
51
45-53
(Suppl 6)
- 24
Morales A.
Yohimbine in erectile dysfunction: would an orphan drug ever be properly assessed?.
World J Urol.
2001;
19
251-255
- 25
Moss A J, Benhorin J.
Prognosis and management after a first myocardial infarction.
N Engl J Med.
1990;
322
743-753
- 26
Muller J E, Mittleman A, Maclure M, Sherwood J B, Tofler G H.
Triggering myocardial infarction by sexual activity. Low absolute risk and prevention
by regular physical exertion. Determinants of Myocardial Infarction Onset Study Investigators.
JAMA.
1996;
275
1405-1409
- 27
Muller J E.
Sexual activity as a trigger for cardiovascular events: what is the risk?.
Am J Cardiol.
1999;
84
2N-5N
- 28
Muller J E.
Triggering of cardiac events by sexual activity: findings from a case-crossover analysis.
Am J Cardiol.
2000;
86
14F-18F
- 29
Porst H.
IC351 (tadalafil, Cialis): update on clinical experience.
Int J Impot Res.
2002;
14
S57-S64
(Suppl 1)
- 30
Rampin O, Giuliano F.
Central control of the cardiovascular and erection systems: possible mechanisms and
interactions.
Am J Cardiol.
2000;
86
19F-22F
- 31
Rampin O, Giuliano F.
Brain control of penile erection.
World J Urol.
2001;
19
1-8
- 32
Russell S T, Khandheria B K, Nehra A.
Erectile dysfunction and cardiovascular disease.
Mayo Clin Proc.
2004;
79
782-794
- 33
Sainz I, Amaya J, Garcia M.
Erectile dysfunction in heart disease patients.
Int J Impot Res.
2004;
16
S13-S17
(Suppl 2)
- 34
Soderling S H, Beavo J A.
Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions.
Curr Opin Cell Biol.
2000;
12
174-179
- 35
Stein R A.
Cardiovascular response to sexual activity.
Am J Cardiol.
2000;
86
27F-29F
- 36
Tardif G S.
Sexual activity after a myocardial infarction.
Arch Phys Med Rehabil.
1989;
70
763-766
- 37
Uckert S, Kuthe A, Stief C G, Jonas U.
Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile
dysfunction.
World J Urol.
2001;
19
14-22
- 38
Ueno M.
The so-called coition death.
Nippon Hoigaku Zasshi.
1963;
17
330-340
- 39
Virag R, Bouilly P, Frydman D.
Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent
men.
Lancet.
1985;
1
181-184
- 40
Wallis R M, Corbin J D, Francis S H, Ellis P.
Tissue distribution of phosphodiesterase families and the effects of sildenafil on
tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae
carneae and aortic rings in vitro.
Am J Cardiol.
1999;
83
3C-12C
- 41
Wespes E, Amar E, Hatzichristou D, Montorsi F, Pryor J, Vardi Y.
Guidelines on erectile dysfunction.
Eur Urol.
2002;
41
1-5
- 42
Yuasa K, Kotera J, Fujishige K, Michibata H, Sasaki T, Omori K.
Isolation and characterization of two novel phosphodiesterase PDE11A variants showing
unique structure and tissue-specific expression.
J Biol Chem.
2000;
275
31469-31479
Dr. Christian Gratzke
Urologische Klinik und Poliklinik, Klinikum Großhadern der Universität München
Marchioninistraße 15
81377 München
Email: Christian.Gratzke@med.uni-muenchen.de
